Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years
Clinical trial NCT04622579 · UNKNOWN
Trial details
- NCT number
- NCT04622579
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2022-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.